References
- Cazzola M, Malcovati L. Myelodysplastic syndromes: coping with ineffective hematopoiesis. N Engl J Med 2005; 352: 536–538
- Bennet J M, Komrokji R S. The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment. Hematology 2005; 10(Suppl 1)258–269
- Catenacci D V, Schiller G J. Myelodysplastic syndromes: a comprehensive review. Blood Rev 2005; 19: 301–319
- Hellström-Lindberg E, Willman C, Barrett J, Saunthararajah Y. Achievements in understanding and treatment of myelodysplastic syndromes. Am Soc of Hematol Educ Program Book 2000; 110–132
- Bennett J, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the acute leukemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458
- Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analyis of 1600 patients. Leuk Res 2000; 24: 983–992
- Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organisation classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
- Rosati S, Mick R, Xu F, Stonys E, Le Beau M M, Larson R, et al. Refractory cytopenia with multilineage dysplasia: further characterization of an ‘unclassifiable’ myelodysplastic syndrome. Leukemia 1996; 10: 20–26
- Greenberg P, Cox C, LeBeau M, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088
- Chatterjee T, Dixit A, Mohapatra M, Tyagi S, Gupta P K, Mishra P, et al. Clinical, haematological and histomorpological profile of adult myelodysplastic syndrome. Study of 96 cases in a single institute. Eur J Haematol 2004; 73: 93–97
- Morel P, Hebbar M, Lai J L, Duhamel A, Preudhomme C, Wattel E, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315–1323
- Sanz G F, Sanz M A, Vallespi T, Canizo M C, Torrabadella M, Garcia S, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
- Malcovati L, Porta M G, Pascutto C, Invernizzi R, Boni M, Travaglino E, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 2005; 23: 7594–7603
- Lorand-Metze I, Pinheiro M P, Ribeiro E, Paula E V, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 2004; 28: 587–594
- Lee J H, Lee J H, Shin Y R, Lee J S, Kim W K, Chi H S, et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 2003; 17: 305–313
- Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, et al. Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution. Blood 2001; 98: 2935–2940
- Bennet J M. A comparative review of classification systems in myelodysplastic syndromes (MDS). Semin Oncol 2005; 32(Suppl 5)3–10
- Howe R B, Porvit-MacDonald A, Wanat R, Tehranchi R, Hellström-Lindberg E. The WHO classification of MDS does make a difference. Blood 2004; 103: 3265–3270
- Jacobs R H, Cornbleet M A, Vardiman J W, Larson R A, Le Beau M M, Rowley J D. Prognostic implication of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–1772
- Breccia M, Carmosino I, Biondo F, Mancini M, Russo E, Latagliata R, et al. Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodysplastic syndromes. Leuk Res 2006; 30: 178–182
- Navarro I, Ruiz M A, Cabello A, Collado R, Ferrer R, Hueso J, et al. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Leuk Res 2006; 30: 971–977